Skip to content

DirectInject 79-45143

by Stryker Leibinger

DirectInject 79-45143 is a Class II device made by Stryker Leibinger, cleared under FDA 510(k) K143661 on 2 Sep 2015 and listed in FDA GUDID since 11 Dec 2018 (UDI-DI 07613327425468), active as of 23 Oct 2026. One FDA recall is linked to it.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

1 closed

Documents

510(k) K143661

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number07613327425468 UDI-DI Date11 Dec 2018ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK143661 Date2 Sep 2015DecidedStatusActive

Official records

Across registries

2 registries list this device

  • FDA 510(k) K143661 decided 2 Sep 2015 Active
  • FDA GUDID UDI-DI 07613327425468 listed 11 Dec 2018 Listed

Recalls

1 recall · FDA

    • Terminated Z-1436-2021 FDA Class II initiated 1 Apr 2021

    Inability for the user to inject the paste from the syringe into the target location.

Timeline

3 dated events

  1. Cleared FDA 510(k) K143661
  2. Listed FDA GUDID 07613327425468
  3. Recall initiated FDA recalls Z-1436-2021

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
DirectInject
Generic name
Orthopaedic bone void filling material, synthetic, bioabsorbable, non-antimicrobial
Model / Ref / Catalog
79-45143
Primary DI / UDI-DI
07613327425468
510(k) Number
FDA product code
GXP
GMDN term
Orthopaedic bone void filling material, synthetic, bioabsorbable, non-antimicrobial
Device class
Class II
Regulation number
882.5300
GUDID distribution status
In Commercial Distribution
Size
Length — 5.0 Centimeter

Related devices

Category: Bone matrix implant, synthetic, non-antimicrobial

Cleared under the same submission (K143661)

Similar devices

Other devices filed under FDA product code GXP (METHYL METHACRYLATE FOR CRANIOPLASTY).

Other devices from Stryker Leibinger

  • 92-55772

    Class II

  • 92-55773

    Class II

  • 92-55771

    Class II

  • 92-55770

    Class II

See all devices from Stryker Leibinger →

Properties

  • Supplied sterile
  • Single use
  • Implantable
  • Prescription use
  • Lot / batch number
  • Expiration date
  • Manufacturing date
Other properties (8, all answered No)